Skip to main content

Table 3 Correlations between percentage change from baseline in UUI episodes and changes in PPBC and KHQ domain scores in subjects treated with TER or placebo

From: Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

 

Placebo

TER

 

r

P Value

r

P Value

PPBC

0.32

<0.0001

0.35

<0.0001

KHQ domain

    

General Health Perceptions

0.11

0.0252

0.09

0.0687

Incontinence Impact

0.27

<0.0001

0.32

<0.0001

Role Limitations

0.30

<0.0001

0.16

0.0008

Physical Limitations

0.25

<0.0001

0.23

0.0001

Social Limitations

0.13

0.0078

0.16

0.0011

Personal Relationships

0.12

0.0436

0.11

0.0773

Emotions

0.14

0.0041

0.25

<0.0001

Sleep/Energy

0.24

<0.0001

0.19

0.0001

Severity/Coping

0.34

<0.0001

0.30

<0.0001

Symptom Severity

0.33

<0.0001

0.32

<0.0001

  1. KHQ = King's Health Questionnaire; PPBC = Patient Perception of Bladder Condition; TER = tolterodine extended release; UUI = urgency urinary incontinence.